• SENSEX
    NIFTY 50
Healthcare

AstraZeneca drags Dr Reddy's Labs to court on patent, says report

Updated : July 25, 2018 12:55 PM IST

AstraZeneca filed a lawsuit in the Delhi High Court against the pharmaceutical major Dr Reddy’s Laboratories to block the company from launching the generic versions of Brilinta.
The court asked Dr Reddy’s on Tuesday to file a reply to the lawsuit and will hear its arguments on July 31.
One of AstraZeneca’s key patents for Brilinta expired in India this month, it has triggered the launch opportunities for local drug makers. 
AstraZeneca drags Dr Reddy's Labs to court on patent, says report

You May Also Like

Live TV
Advertisement